Remove category opinion
article thumbnail

April 18, 2024: New Living Textbook Chapter Articulates How Investigators Navigated Unexpected Challenges During Pragmatic Clinical Trials

Rethinking Clinical Trials

Sections 6 and 7 describe challenges that can fall into either category 1 or 2, and investigators had to decide how to respond in real time. Section 6 : Clinical practice guidelines and policies changed due to new evidence from observational studies, small trials, and shifting expert opinion, and therefore, usual care changed.

article thumbnail

Telehealth: Supply exceeds demand

World of DTC Marketing

Then there is this nugget; 79% of telehealth patients had between one and four visits between 2020 and 2021, with less than 3% of telehealth patients falling into the “Super Utilizer Category” of having 25 or more telehealth visits in the same timeframe. In my opinion, this is an excellent report.

Marketing 206
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Why DTC isn’t, and is, marketing

World of DTC Marketing

But, in pharma marketing, the changes affect every product category. I’ve seen posts on everything from opinions on detergents to the best and more inexpensive ice cream. CPG marketers are trying to maintain market share amid price increases and smaller product sizes, leading to a more significant jump in consumerism.

Marketing 252
article thumbnail

Data-Led Digital KOL Engagement

pharmaphorum

When creating engagement plans for individual Digital Key Opinion Leaders (DOLs), it’s best to look at a range of data-led metrics about each DOL to fine tune the engagement and maximise benefit for all parties. data multiplier, content creator, opinion former, proactive educator, etc.), A plethora of such phenotypes are possible (e.g.

article thumbnail

Latest CMS Data Reveal the Truth About U.S. Drug Spending

Drug Channels

I examine the growth rates of major spending categories, break down costs vs. utilization, and highlight the unfavorable out-of-pocket dynamics for prescription drugs compared with hospital care. Regular readers know the unofficial motto of Drug Channels : "Everyone is entitled to their own opinion, but not their own facts."

Drugs 52
article thumbnail

CHMP backs Amicus’ therapy for Pompe disease

pharmaphorum

Amicus Therapeutics could be just weeks away from getting EU approval for its new Pompe disease therapy Pombiliti after getting a positive opinion on the drug from the EMA’s human medicines committee. Sanofi makes more than $1 billion a year from its Pompe disease franchise.

article thumbnail

Anti-Counterfeiting Technologies in Healthcare

Roots Analysis

Anti-counterfeiting technologies technologies can be broadly classified under two categories, namely Authentication Technologies and Track & Trace Technologies. Each category has its own set of advantages and disadvantages. Overt security features are basically security checkpoints that are meant for end users.